Inbunden, Engelska, 2009
Biotechnology Valuation
An Introductory Guide
Av Karl Keegan
Del i serien The Wiley Finance Series
896 kr
Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt över 249 kr.
Fler format och utgåvor
Beskrivning
Produktinformation
- Utgivningsdatum: 2009-01-09
- Mått: 165 x 244 x 25 mm
- Vikt: 568 g
- Format: Inbunden
- Språk: Engelska
- Serie: The Wiley Finance Series
- Antal sidor: 224
- Förlag: John Wiley & Sons Inc
- ISBN: 9780470511787
Utforska kategorier
Mer om författaren
KARL KEEGAN is currently a managing director and global head of life sciences equity research at CanaccordAdams, a global investment bank focussing on small to mid cap companies. Karl has been a financial analyst covering the biotechnology sector for over eleven years and has previously worked at Dresdner Kleinwort Benson, UBS and Banc of America. Karl and his team have been consistently highly ranked in institutional surveys throughout his career. Prior to embarking on his finance career, Karl completed postdoctoral assignments in the US and UK and worked in the pharmaceutical industry both as a bench scientist and in strategic planning. Dr. Keegan holds a BSc in Pharmacology from University College Dublin, Ireland, MPhil and PhD degrees in Pharmacology from University of Cambridge, UK and MSc in Finance from London Business School, UK. A native of Dublin, Ireland, he now lives in Kent, UK.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.